Labarai

Ana sa ran masana'antar likitancin kasar Sin za ta taka rawar gani a duniya wajen yin kirkire-kirkire tare da kara yin amfani da fasahohin zamani kamar fasahar kere-kere da sarrafa kansa, musamman ma lokacin da fannin ya yi zafi wajen zuba jari a tsakanin annobar COVID-19, in ji fitaccen mai saka jari na kasar Sin Kai-Fu. Lee.

“Kimiyyar rayuwa da sauran sassan kiwon lafiya, waɗanda a da suke ɗaukar dogon lokaci don haɓaka, an haɓaka su a cikin ci gaban su yayin bala'in.Tare da taimakon AI da sarrafa kansa, an sake fasalin su kuma an inganta su don su zama masu hankali da ƙima, ”in ji Lee, wanda kuma shi ne shugaba kuma Shugaba na babban kamfani na Sinovation Ventures.

Lee ya bayyana canjin a matsayin zamanin likitanci da X, wanda galibi yana nufin haɓaka haɗin gwiwar fasahar gaba cikin masana'antar likitanci, alal misali, a sassan da suka haɗa da haɓaka magunguna na taimako, ainihin ganewar asali, jiyya na mutum ɗaya da mutummutumi na tiyata.

Ya ce masana'antar tana yin zafi sosai don saka hannun jari saboda barkewar cutar, amma a yanzu tana fitar da kumfa don shiga cikin lokaci mai ma'ana.Kumfa yana faruwa ne lokacin da masu zuba jari suka yi wa kamfanoni daraja.

"Wataƙila kasar Sin za ta ci gaba da samun bunkasuwa a cikin irin wannan zamanin, kuma za ta jagoranci sabbin fasahohin duniya a fannin kimiyyar rayuwa cikin shekaru 20 masu zuwa, musamman godiya ga ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ma'aikata, da damammaki daga manyan bayanai da kasuwannin cikin gida guda ɗaya, da kuma ƙoƙarin da gwamnati ta yi. a tuki sabbin fasahohi,” in ji shi.

Bayanin ya zo ne a daidai lokacin da bangaren kiwon lafiya da na kiwon lafiya ke ci gaba da zama a cikin manyan masana'antu uku da suka fi fice don zuba jari, sannan kuma suna matsayi na farko a cikin yawan kamfanonin da suka yi nasarar ficewa bayan fara ba da kyauta ga jama'a a rubu'in farko na wannan shekara, a cewar Zero2IPO. Bincike, mai ba da bayanan sabis na kuɗi.

Wu Kai, abokin hadin gwiwar Sinovation Ventures ya ce "Hakan ya nuna cewa fannin likitanci da kiwon lafiya ya zama daya daga cikin 'yan abubuwan da suka fi dacewa ga masu zuba jari a wannan shekara kuma suna da darajar zuba jari a cikin dogon lokaci."

A cewar Wu, sana'ar ba ta tsaya ga sassa na gargajiya na tsaye ba kamar su likitanci, na'urorin likitanci da kuma aiyuka, kuma suna rungumar hadewar karin ci gaban fasaha.

Ɗaukar bincike da haɓaka alurar riga kafi a matsayin misali, ya ɗauki watanni 20 kafin rigakafin SARS (mai tsanani mai tsanani na numfashi) don shiga gwaji na asibiti bayan gano kwayar cutar a cikin 2003, yayin da aka ɗauki kwanaki 65 kawai kafin rigakafin COVID-19 ya shiga. gwaji na asibiti.

"Ga masu zuba jari, ya kamata a ba da himma mai dorewa ga irin waɗannan sabbin fasahohin fasahar likitanci don fitar da nasarorin da suka samu da kuma gudummawar da suke bayarwa ga dukkan sassan," in ji shi.

Alex Zhavoronkov, wanda ya kafa kuma Shugaba na Insilico Medicine, farawa da ke amfani da AI don haɓaka sababbin magunguna, ya yarda.Zhavoronkov ya ce, ba batun batun ko kasar Sin za ta zama cibiyar samar da magunguna ta AI ba.

"Tambayar da ta rage ita ce 'yaushe hakan zai faru?'Lallai kasar Sin tana da cikakken tsarin ba da goyon baya ga masu farawa da manyan kamfanonin harhada magunguna don yin amfani da fasahar AI da kyau wajen samar da sabbin magunguna," in ji shi.